March 3, 2021Open Access

The Potentially Modifiable Risk Factor in Idiopathic Intracranial Hypertension

SMSusan P. MollanUniversity Hospitals Birmingham NHS Foundation Trust ATAbd A. TahraniBirmingham City University ASAlexandra J. SinclairNIHR Surgical Reconstruction and Microbiology Research Centre

Key Points

Key points are not available for this paper at this time.

Abstract

New research evaluating the pathophysiology of IIH supports GLP-1 RA as a potential treatment for IIH via weight loss dependent and independent mechanism to directly reduce ICP.

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Mollan et al. (Wed,) studied this question.

synapsesocial.com/papers/69dd4d92fb7610310c101e20 https://doi.org/https://doi.org/10.1212/cpj.0000000000001063

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Profiles of Obesity, Weight Gain, and Quality of Life in Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)2007 · 320 citations
2The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement2020 · 167 citations
3Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study2010 · 355 citations
4Body composition status and the risk of migraine2017 · 116 citations
5Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis2018 · 160 citations

AI에게 질문

Bookmark

View Full Paper